Equities
  • Price (EUR)17.50
  • Today's Change-1.70 / -8.85%
  • Shares traded4.00
  • 1 Year change+10.76%
  • Beta0.9830
Data delayed at least 15 minutes, as of Feb 12 2026 14:25 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Mirion Technologies, Inc. is a global provider of radiation detection, measurement, analysis, and monitoring solutions to the nuclear, medical, defense, and research end markets. The Company's segments include Medical, and Nuclear & Safety. The Medical segment includes products and services for radiation therapy, nuclear medicine and personal dosimetry. This segment’s principal product offering is in Radiation Therapy Quality Assurance, which includes solutions for calibrating and/or verifying imaging, treatment machine, patient treatment plan, and patient treatment accuracy. The Nuclear & Safety segment includes products and services focused on addressing critical radiation safety, measurement and analysis applications across nuclear energy, laboratories and research and other industrial markets such as defense. For nuclear power plants (NPPs), it sells products and services for use at any stage of their life (construction, operation, decommissioning and dismantling).

  • Revenue in USD (TTM)925.40m
  • Net income in USD28.80m
  • Incorporated2018
  • Employees3.00k
  • Location
    Mirion Technologies Inc1218 Menlo DriveATLANTA 30318United StatesUSA
  • Phone+1 (770) 432-2744
  • Fax+1 (302) 636-5454
  • Websitehttps://www.mirion.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
MIR:NYQ since
announced
Transaction
value
Paragon Energy Solutions LLCDeal completed24 Sep 202524 Sep 2025Deal completed-13.37%585.00m
Crimson Engineered Solutions LLCDeal completed31 Jul 202531 Jul 2025Deal completed-4.95%--
Data delayed at least 15 minutes, as of Feb 12 2026 17:24 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.